Glutamate metabotropic receptors as targets for drug therapy in epilepsy

European Journal of Pharmacology

Volumn 476, Issue 1-2, 2003, Pages 3-16

  Moldrich, Randal X ^a   Chapman, Astrid G ^b   De Sarro, Giovambattista ^c   Meldrum, Brian S ^b  

^a MONASH UNIVERSITY   (Australia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Anticonvulsant; DBA 2 mouse; Epilepsy; Glutamate receptor, metabotropic; Kindling; Temporal lobe epilepsy

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; 1 AMINOCYCLOPENTANE 1,2,4 TRICARBOXYLIC ACID AGONIST; 2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 AMINO 2 (3 CARBOXYCYCLOBUTYL) 3 (9 THIOXANTHYL)PROPIONIC ACID; 2 AMINO 2 (3 CARBOXYCYCLOBUTYL) 3 (9H XANTHEN 9 YL)PROPANOIC ACID ANTAGONIST; 2 AMINO 2 (4 CARBOXYPHENYL) 3 (9 THIOXANTHYL)PROPIONIC ACID; 2 AMINO 2 (4 CARBOXYPHENYL) 3 (9H XANTHEN 9 YL)PROPANOIC ACID ANTAGONIST; 2 METHYL 3 HYDROXY 4 CARBOXYPHENYLGLYCINE ANTAGONIST; 2 METHYL 6 (2 PHENYLVINYL)PYRIDINE; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 2 THIA 4 AMINOBICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLATE; 3,4 DICARBOXYPHENYLGLYCINE AGONIST; 3,5 DIHYDROXYPHENYLGLYCINE; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 AMINO 2 THIABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 CARBOXY 2 METHYLPHENYLGLYCINE; 4 METHOXYPHENYL (6 METHOXYQUINAZOLIN 4 YL)AMINE; 4 PHOSPHONOPHENYLGLYCINE AGONIST; 6A NAPHTHALEN 2 YLMETHYL 5 METHYLIDENE HEXAHYDROCYCLOPENTA[C]FURAN 1 ONE; ANTICONVULSIVE AGENT; BAY 36 7620; DIAZEPAM; DIZOCILPINE; EGLUMETAD; LEVO 2 AMINO 4 PHOSPHONOBUTYRIC ACID AGONIST; LY 339764; LY 339840; LY 367335; LY 456236; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; PHOSPHOSERINE AGONIST; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABSENCE; ANTICONVULSANT ACTIVITY; COMPLEX PARTIAL SEIZURE; DRUG ANTAGONISM; DRUG COMPETITION; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG POTENCY; DRUG TARGETING; EPILEPSY; GRAND MAL SEIZURE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE;

EID: 0142183302     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)02149-6     Document Type: Review

References (129)

1. Abdul-Ghani A.S., Attwell P.J.E., Kent N.S., Bradford H.F., Croucher M.J., Jane D.E. Anti-epileptogenic and anticonvulsant activity of L-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonist. Brain Res. 755:1997;202-212.
2. Akbar M.T., Rattray M., Powell J.F., Meldrum B.S. Altered expression of group I metabotropic glutamate receptors in the hippocampus of amygdala-kindled rats. Brain Res. Mol. Brain Res. 43:1996;105-116.
3. Akiyama K., Yamada N., Otsuki S. Long lasting increase in excitatory amino acid receptor-mediated polyphosphoinositide hydrolysis in the amygdala/pyriform cortex of amygdala-kindled rats. Brain Res. 485:1989;95-101.
4. Akiyama K., Daigen A., Yamada N., Itoh T., Kohira I., Ujike H., Otsuki S. Long-lasting enhancement of metabotropic excitatory amino acid receptor-mediated polyphosphoinositide hydrolysis in the amygdala/pyriform cortex of deep prepiriform cortical kindled rats. Brain Res. 569:1992;71-77.
5. Akiyama K., Ono M., Kohira I., Daigen A., Ishihara T., Kuroda S. Long lasting increase in protein kinase C activity in the hippocampus of amygdala-kindled rat. Brain Res. 679:1995;212-220.
6. Alagarsamy S., Sorensen S.D., Conn P.J. Coordinate regulation of metabotropic glutamate receptors. Curr. Opin. Neurobiol. 11:2001;357-362.
7. Al-Ghoul W.M., Meeker R.B., Greenwood R.S. Kindled seizures increase metabotropic glutamate receptor expression and function in the rat supraoptic nucleus. J. Neurosci. Res. 54:1998;412-423.
8. Anwyl R. Metabotropic glutamate receptors: electrophysiological properties and role in plasticity. Brain Res. Rev. 29:1999;83-120.
9. Aronica E., van Vliet E.A., Mayboroda O.A., Troost D., da Silva F.H., Gorter J.A. Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy. Eur. J. Neurosci. 12:2000;2333-2344.
10. Attwell P.J., Kaura S., Sigala G., Bradford H.F., Croucher M.J., Jane D.E., Watkins J.C. Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonist. Brain Res. 698:1995;155-162.
11. Attwell P.J.E., Kent N.S., Jane D.E., Croucher M.J., Bradford H.F. Anticonvulsant and metabotropic glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2′R,3′R)- 2-(2′,3′-dicarboxycyclopropyl)glycine (DCG-IV). Brain Res. 805:1998;138-143.
12. Attwell P.J.E., Koumentaki A., Abdul-Ghani A.S., Croucher M.J., Bradford H.F. Specific group II glutamate receptor activation inhibits the development of kindled epilepsy in rats. Brain Res. 787:1998;286-291.
13. Battaglia G., Bruno V., Pisani A., Centonze D., Catania M.V., Calabresi P., Nicoletti F. Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing GABAergic transmission. Mol. Cell. Neurosci. 17:2001;1071-1083.
14. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 14:1985;375-403.
15. Blumcke I., Becker A.J., Klein C., Scheiwe C., Lie A.A., Beck H., Waha A., Friedl M.G., Kuhn R., Emson P., Elger C., Wiestler O.D. Temporal lobe epilepsy associated up-regulation of metabotropic glutamate receptors: correlated changes in mGluR1 mRNA and protein expression in experimental animals and human patients. J. Neuropathol. Exp. Neurol. 59:2000;1-10.
16. Bourgeois B.F. New antiepileptic drugs. Arch. Neurol. 55:1998;1181-1183.
17. Bräuner-Osbourne H., Egebjerg J., Nielsen E.Ø., Madsen U., Krogsgaard-Larsen P. Ligands for glutamate receptors: design and therapeutic prospects. J. Med. Chem. 43:2000;2609-2645.
18. Britton T., Barda D., Hornback W., Jagdmann G.E., Henry S., Fichtner M., Wang Z.-Q., Coleman D., Chenoweth D., Vaught G., Fivush A., Dressman B., White R., Milot G., Herr R.J., Burry L., Johnson M., Large T., Monn J., Schoepp D.D. Selective non-amino-acid allosteric potentiators of mGlu2 receptors. Neuropharmacology. 43:2002;279.
19. Camón L., Vives P., de Vera N., Martinez E. Seizures and neuronal damage induced in the rat by activation of group I metabotropic glutamate receptors with their selective agonist 3,5-dihydroxyphenylglycine. J. Neurosci. Res. 51:1998;339-348.
20. Camón L., de Vera N., Martinez E. Polyamine metabolism and glutamate receptor agonists-mediated excitotoxicity in the rat brain. J. Neurosci. Res. 66:2001;1101-1111.
21. Carroll F.Y., Stolle A., Beart P.M., Voerste A., Brabet I., Mauler F., Joly C., Antonicek H., Bockaert J., Müller T., Pin J.-P., Prézeau L. BAY36-7620: a potent noncompetitive mGlu1 receptor antagonist with inverse agonist activity. Mol. Pharmacol. 59:2001;965-973.
22. Cartmell J., Schoepp D.D. Regulation of neurotransmitter release by metabotropic glutamate receptors. J. Neurochem. 75:2000;889-907.
23. Chapman A.G., Smith S.E., Meldrum B.S. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466. Epilepsy Res. 9:1991;92-96.
24. Chapman A.G., Elwes R.D.C., Millan M.H., Polkey C.E., Meldrum B.S. Role of glutamate and aspartate in epileptogenesis; contribution of microdialysis studies in animals and man. Prog. Nat. Epileptogenesis. 12:1996;239-246. (Epilepsy Res. Suppl. 12).
25. Chapman A.G., Yip P.K., Yap J.S., Quinn L.P., Tang E., Harris J.R., Meldrum B.S. Anticonvulsant actions of LY 367385 ((+)-2-methyl-4- carboxyphenylglycine) and AIDA ((R,S)-1-aminoindan-1,5-dicarboxylic acid). Eur. J. Pharmacol. 368:1999;17-24.
26. Chapman A.G., Nanan K., Yip P., Meldrum B.S. Anticonvulsant activity of a metabotropic glutamate receptor 8 preferential agonist, (R,S)- phosphonophenylglycine. Eur. J. Pharmacol. 383:1999;23-27.
27. Chapman A.G., Nanan K., Meldrum B.S., Schreiber R., DeVry J., Müller T. Anticonvulsant activity in mice of BAY36-7620, a novel, selective mGluR1 antagonist. Soc. Neurosci. Abstr. 26:2000;1650.
28. Chapman A.G., Nanan K., Williams M., Meldrum B.S. Anticonvulsant activity of two metabotropic glutamate Group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893). Neuropharmacology. 39:2000;1567-1574.
29. 4α receptor selective agonist, (1S,3R,4S)-1- aminocyclopentane-1,2,4-tricarboxylic acid. Eur. J. Pharmacol. 424:2001;107-113.
30. Conn P.J., Pin J.-P. Pharmacology and functions of metabotropic glutamate receptors. Ann. Rev. Pharmacol. Toxicol. 37:1997;205-237.
31. Cosford N.D.P., Tehrani L., Arruda J., King C., McDonald I.A., Munoz B., Roppe J., Schweiger E., Smith N., Wang B., Zhang K., Anderson J., Bristow L., Brodkin J., Rao S., Siegel R., Tattersall D., Washburn M., Prasit P., Varney M. 3-[(2-methyl-1,3-thiazol-4-yl)pyridine (MTEP): design and synthesis of a potent and highly selective metabotropic glutamate subtype 5 (mGlu5) receptor antagonist with anxiolytic activity. Neuropharmacology. 43:2002;282.
32. Dalby N.O., Thomsen C. Modulation of seizure activity in mice by metabotropic glutamate receptor ligands. J. Pharmacol. Exp. Ther. 276:1996;516-522.
33. Dale L.B., Babwah A.V., Ferguson S.S. Mechanisms of metabotropic glutamate receptor desensitization: role in the patterning of effector enzyme activation. Neurochem. Int. 41:2002;319-326.
34. De Sarro G., Gitto R., Rizzo M., Zappia M., De Sarro A. 1,4-Benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice. Gen. Pharmacol. 27:1996;935-941.
35. De Sarro G., Gratteri S., Bonacci F., Musumeci S.A., Elia M., De Sarro A. Topiramate potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Eur. J. Pharmacol. 388:2000;163-170.
36. De Sarro G., Chimirri A., Meldrum B.S. Group II mGlu agonists potentiate the anticonvulsant effect of AMPA and NMDA receptor block. Eur. J. Pharmacol. 451:2002;55-61.
37. Dietrich D., Kral T., Clusmann H., Friedl M., Schramm J. Reduced function of L-AP4-sensitive metabotropic glutamate receptors in human epileptic sclerotic hippocampus. Eur. J. Pharmacol. 11:1999;1109-1113.
38. Doherty A.J., Dingledine R. The roles of metabotropic glutamate receptors in seizures and epilepsy. Curr. Drug Targets: CNS Neurol. Dis. 1:2002;251-260.
39. Doherty A.J., Palmer M.J., Henley J.M., Collingridge G.L., Jane D.E. (R,S)-2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but not mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology. 36:1997;265-267.
40. D'Onofrio M., Cuomo L., Battaglia G., Ngomba R.T., Storto M., Kingston A.E., Orzi F., De Blasi A., Di Iorio P., Nicoletti F., Bruno V. Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways. J. Neurochem. 78:2001;435-445.
41. Folbergrová J., Haugvicová R., Mareš P. Attenuation of seizures induced by homocysteic acid in immature rats by metabotropic glutamate group II and group III receptor agonists. Brain Res. 908:2001;120-129.
42. Folbergrová J., Haugvicová R., Mareš P. Seizures induced by homocysteic acid in immature rats are prevented by group III metabotropic glutamate receptor agonist (R,S)-4-phosphophenylglycine. Exp. Neurol. 180:2003;46-54.
43. Friedl M., Clusmann H., Kral T., Dietrich D., Schramm J. Analysing metabotropic glutamate group III receptor mediated modulation of synaptic transmission in the amygdala-kindled dentate gyrus of the rat. Brain Res. 821:1999;117-123.
44. Gasparini F., Bruno V., Battaglia G., Lukic S., Leonhardt T., Inderbitzin W., Laurie D., Sommer B., Varney M.A., Hess S.D., Johnson E.C., Kuhn R., Urwyler S., Sauer D., Portet C., Schmutz M., Nicoletti F., Flor P.J. (R,S)-4-Phosphonophenylglycine, a potent and selective Group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. J. Pharmacol. Exp. Ther. 290:1999;1678-1687.
45. Gasparini F., Kuhn R., Pin J.-P. Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives. Curr. Opin. Pharmacol. 2:2002;43-49.
46. Gerlai R., Adams B., Fitch T., Chaney S., Baez M. Performance deficits of mGluR8 knockout mice in learning tasks: the effects of null mutation and the background genotype. Neuropharmacology. 43:2002;235-249.
47. Ghauri M., Chapman A.G., Meldrum B.S. Convulsant and anticonvulsant actions of agonists and antagonists of group III mGluRs. NeuroReport. 7:1996;1469-1474.
48. Gower A.J., Hirsch E., Boehrer A., Noyer M., Marescaux C. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res. 22:1992;207-213.
49. Greenwood R.S., Fan Z., McHugh R., Meeker R. Inhibition of hippocampal kindling by metabotropic glutamate receptor antisense oligonucleotides. Mol. Cell. Neurosci. 16:2000;233-243.
50. Heidinger V., Manzerra P., Wang X.Q., Strasser U., Yu S.P., Choi D.W., Behrens M.M. Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the Pyk2/Src-family kinase pathway in cortical neurons. J. Neurosci. 22:2002;5452-5461.
51. Hermans E., Nahorski S.R., Challis R.A. Reversible and noncompetitive antagonist profile of CPCCOEt at the human type 1alpha metabotropic glutamate receptor. Neuropharmacology. 37:1998;1645-1647.
52. Holmes K.H., Keele N.B., Shinnick-Gallagher P. Loss of mGluR-mediated hyperpolarizations and increase in mGluR depolarizations in basolateral amygdala neurons in kindling-induced epilepsy. J. Neurophysiol. 76:1996;2808-2816.
53. Houamed K.M., Kuijper J.L., Gilbert T.L., Haldeman B.A., O'Hara P.J., Mulvihill E.R., Almers W., Hagen F.S. Cloning, expression, and gene structure of a G-protein coupled glutamate receptor from rat brain. Science. 252:1991;1318-1321.
54. Huguenard J.R., Prince D.A. Clonazepam suppresses GABAB-mediated inhibition in thalamic relay neurons through effects in nucleus reticularis. J. Neurophysiol. 71:1994;2576-2581.
55. Johnston G.A.R. Convulsions induced in 10-day-old rats by intraperitional injection of monosodium glutamate and related excitant amino acids. Biochem. Pharmacol. 22:1973;137-140.
56. Keele N.B., Zinebi F., Neugebauer V., Shinnick-Gallagher P. Epileptogenesis up-regulates metabotroppic glutamate receptor activation of sodium-calcium exchange current in the amygdala. J. Neurophysiol. 83:2000;2458-2462.
57. Kingston A.E., Griffey K., Johnson M.P., Chamberlain M.-J., Kelly G., Tomlinson R., Wright R.A., Johnson B.G., Schoepp D.D., Harris J.R., Clark B.P., Baker R.S., Tizzano J.P. Inhibition of group I metabotropic glutamate receptor responses in vivo in rats by a new generation of carboxyphenylglycine-like amino acid antagonists. Neurosci. Lett. 330:2002;127-130.
58. Klapstein G.J., Meldrum B.S., Mody I. Decreased sensitivity to Group III mGluR agonists in the lateral perforant path following kindling. Neuropharmacology. 38:1999;927-933.
59. Klodzinska A., Chojnacka-Wojcik E., Pilc A. Selective group II glutamate metabotropic receptor agonist LY 354740 attenuates pentetrazole- and picrotoxin-induced seizures. Pol. J. Pharmacol. 51:1999;543-545.
60. Kral T., Erdmann E., Sochivko D., Clusmann H., Schramm J., Dietrich D. Down-regulation of mGluR8 in pilocarpine epileptic rats. Synapse. 47:2003;278-284.
61. Kuhn R., Pagano A., Stoehr N., Vranesic I., Flor P.J., Lingenhohl K., Spooren W., Gentsch C., Vassout A., Pilc A., Gasparini F. In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article. Amino Acids. 23:2002;207-211.
62. Lan J.Y., Skeberdis V.A., Jover T., Zheng X., Bennett M.V.L., Zukin R.S. Activation of metabotropic glutamate receptor 1 accelerates NMDA receptor trafficking. J. Neurosci. 21:2001;6058-6068.
63. Lanneau C., Harries M.H., Ray A.M., Cobb S.R., Randall A., Davies C.H. Complex interactions between mGluR1 and mGluR5 shape neuronal network activity in the rat hippocampus. Neuropharmacology. 43:2002;131-140.
64. Lesage A.S.J., Bischoff F., van Beijsterveldt L., Meert T., Steckler T., Ashton D. Novel, centrally active mGlu1 antagonists: in vitro and in vivo pharmacology. Neuropharmacology. 43:2002;295.
65. 2 challenge in patients diagnosed with panic disorder. Neuropharmacology. 43:2002;294.
66. Li L., Tomlinson R., Wang Y., Tsui H.-C.T., Chamberlain M.-J., Johnson M.P., Baez M., Vannieuwenhze M.S., Zia-Ebrahimi M., Hong E.J., Schkeryantz J.M., Monn J.A., Porter W.J., Baker S.R., Owton W.M., Clark B.P., Kingston A.E. A novel series of potent and selective noncompetitive antagonists of metabotropic glutamate receptor 1. Neuropharmacology. 43:2002;295.
67. Lie A.A., Becker A., Behle K., Beck H., Malitschek B., Conn P.J., Kuhn R., Nitsch R., Plaschke M., Schramm J., Elger C.E., Wiestler O.D., Blumcke I. Up-regulation of the metabotropic glutamate receptor mGluR4 in hippocampal neurons with reduced seizure vulnerability. Ann. Neurol. 47:2000;26-35.
68. Mannaioni G., Marino M.J., Valenti O., Traynelis S.F., Conn P.J. Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. J. Neurosci. 21:2001;5925-5934.
69. Marino M.J., Wittmann M., Bradley S.R., Hubert G.W., Smith Y., Conn P.J. Activation of Group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata. J. Neurosci. 21:2001;7001-7012.
70. Mathiesen J.M., Svendsen N., Brauner-Osborne H., Thomsen C., Ramirez M.T. Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP. Br. J. Pharmacol. 138:2003;1026-1030.
71. Masu M., Tanabe Y., Tsuchida K., Shigemoto R., Nakanishi S. Sequence and expression of a metabotropic glutamate receptor. Nature. 349:1991;760-765.
72. Mayat E., Lerner-Natoli M., Rondouin G., Lebrun F., Sassetti I., Recasens M. Kainate-induced status epilepticus leads to a delayed increase in various specific glutamate receptor responses in the hippocampus. Brain Res. 645:1994;186-200.
73. Meldrum B.S. Excitotoxicity and epileptic brain damage. Epilepsy Res. 10:1991;55-61.
74. Meldrum B.S., Chapman A.G. Epileptic seizures and epilepsy. Siegel G.J. et al. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 1999;755-768 Lippincott-Raven Publishers, Philadelphia.
75. Meldrum B.S., Craggs M.D., Durmuller N.S., Chapman A.G. The effects of AMPA receptor antagonists on kindled seizures and on reflex epilepsy in rodents and primates. Epilepsy Res.-Suppl. 9:1992;307-311.
76. Meldrum B.S., Ghauri M., Tang E., Yip P.K., Jane D.E., Watkins J.C., Chapman A.G. Glutamate metabotropic receptors: anticonvulsant and convulsant effects of group II agonists and antagonists. Soc. Neurosci. Abstr. 22:1996;1036.
77. Meldrum B.S., Akbar M.T., Chapman A.G. Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy Res. 36:1999;189-204.
78. Merlin J.R. Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts. J. Neurophysiol. 87:2002;621-625.
79. Messenger M.J., Dawson L.G., Duty S. Changes in metabotropic glutamate receptor 1-8 gene expression in the rodent basal ganglia motor loop following lesion of the nigrostriatal tract. Neuropharmacology. 43:2002;261-271.
80. Minakami R., Jinnai N., Sugiyama H. Phosphorylation and calmodulin binding of the metabotropic glutamate receptor subtype 5 (mGluR5) are antagonistic in vitro. J. Biol. Chem. 272:1997;20291-20298.
81. Minami I., Kengaku M., Smitt P.S., Shigemoto R., Hirano T. Long-term potentiation of mGluR1 activity by depolarization-induced Homer1a in mouse cerebellar Purkinje neurons. Eur. J. Neurosci. 17:2003;1023-1032.
82. Miyamoto M., Ishida M., Shinozaki H. Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat. Neuroscience. 77:1997;131-140.
83. Moldrich R.X., Beart P.M. Emerging signalling and protein interactions mediated via metabotropic glutamate receptors. Curr. Drug Targets-CNS Neurol. Dis. 2:2003;109-122.
84. Moldrich R.X., Beart P.M., Jane D.E., Chapman A.G., Meldrum B.S. Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice. Neuropharmacology. 40:2001;732-735.
85. Moldrich R.X., Jeffrey M., Talebi A., Beart P.M., Chapman A.G., Meldrum B.S. Antiepileptic activity of group II metabotropic glutamate receptor agonists (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (-)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY3897950). Neuropharmacology. 41:2001;8-18.
86. Moldrich R.X., Talebi A., Beart P.M., Chapman A.G., Meldrum B.S. The mGlu2/3 agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate, is anti- and proconvulsant in DBA/2 mice. Neurosci. Lett. 299:2001;125-129.
87. Movsesyan V.A., O'Leary D.M., Fan L., Bao W., Mullins P.G.M., Knoblach S.M., Faden A.I. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 296:2001;41-47.
88. Mutel V., Adam G., Jolidon S., Kemp J.A., Kew J.N., Maerki H.P., Malherbe P., Vieira E., Wichmann J., Wostl W., Knoflach F. Characterization of novel modulators of mGlu1 receptors: pharmacology, specificity and binding site. Neuropharmacology. 43:2002;300.
89. Nakanishi S., Nakajima Y., Masu M., Ueda Y., Nakahara K., Watanabe D., Yamaguchi S., Kawabata S., Okada M. Glutamate receptors: brain function and signal transduction. Brain Res. Rev. 26:1998;230-235.
90. Neugebauer V., Keele N.B., Shinnick-Gallagher P. Epileptogenesis in vivo enhances the sensitivity of inhibitory presynaptic metabotropic glutamate receptors in basolateral amygdala neurons in vitro. J. Neurosci. 17:1997;983-995.
91. Neugebauer V., Zinebi F., Russell R., Gallagher J.P., Shinnick-Gallagher P. Cocaine and kindling alter the sensitivity of group II and III metabotropic glutamate receptors in the central amygdala. J. Neurophysiol. 84:2000;759-770.
92. O'Connor V., El Far O., Bofill-Cardona E., Nanoff C., Freissmuth M., Karschin A., Airas J.M., Betz H., Boehm S. Calmodulin dependence of presynaptic metabotropic glutamate receptor signaling. Science. 286:1999;1180-1184.
93. O'Leary D.M., Movsesyan V., Vicini S., Faden A.I. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism. Br. J. Pharmacol. 131:2000;1429-1437.
94. Pagano A., Ruegg D., Litschig S., Stoehr N., Stierlin C., Heinrich M., Floersheim P., Prezeau L., Carroll F., Pin J.-P. The noncompetitive antagonists 2-methyl-6-(phenylethynyl)pyridine and 7-hydroxyiminocyclopropan[b]chromen-1a- carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group-I metabotropic glutamate receptors. J. Biol. Chem. 275:2000;33750-33758.
95. Pin J.-P., Acher F. The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. Curr. Drug Targets-CNS Neurol. Dis. 1:2002;297-317.
96. Pin J.-P., De Colle C., Bessis A-S., Acher F. New perspectives for the development of selective metabotropic glutamate receptor ligands. Eur. J. Pharmacol. 375:1999;277-294.
97. Potschka H., Krupp E., Ebert U., Gumbel C., Leichtlein C., Lorch B., Pickert A., Kramps S., Young K., Grune U., Keller A., Welschof M., Vogt G., Xiao B., Worley P.F., Loscher W., Hiemisch H. Kindling-induced overexpression of Homer 1A and its functional implications for epileptogenesis. Eur. J. Neurosci. 16:2002;2157-2165.
98. Renaud J., Emond M., Meilleur S., Psarropoulou C., Carmant L. AIDA, a class I metabotropic glutamate-receptor antagonist limits kainate-induced hippocampal dysfunction. Epilepsia. 43:2002;1306-1317.
99. Rouse S.T., Marino M.J., Bradley S.R., Awad H., Wittmann M., Conn P.J. Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's Disease and related disorders. Pharmacol. Ther. 88:2000;427-435.
100. Sansig G., Bushell T.J., Clarke V.R., Rozov A., Burnashev N., Portet C., Gasparini F., Schmutz M., Klebs K., Shigemoto R., Flor P.J., Kuhn R., Knoepfel T., Schroeder M., Hampson D.R., Collett V.J., Zhang C., Duvoisin R.M., Collingridge G.L., van Der Putten H. Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7. J. Neurosci. 21:2001;8734-8745.
101. Saugstad J.A., Kinzie J.M., Shinohara M.M., Segerson T.P., Westbrook G.L. Cloning and expression of rat metabotropic glutamate receptor 8 reveals a distinct pharmacological profile. J. Neurosci. 17:1997;119-125.
102. Schaffhauser H., Cai Z., Hubalek F., Macek T.A., Pohl J., Murphy T.J., Conn P.J. cAMP-dependent protein kinase inhibits mGluR2 coupling to G-proteins by direct receptor phosphorylation. J. Neurosci. 20:2000;5663-5670.
103. Schoepp D.D. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J. Pharmacol. Exp. Ther. 299:2001;12-20.
104. Schoepp D.D., Salhoff C.R., Wright R.A., Johnson B.G., Burnett J.P., Mayne N.G., Belagaje R., Wu S., Monn J.A. The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors. Neuropharmacology. 35:1996;1661-1672.
105. Schoepp D.D., Jane D.E., Monn J.A. Pharmacologic agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology. 38:1999;1431-1476.
106. Shannon H.E., Peters S.C. Anticonvulsant effect of the selective mGlu1 receptor antagonist LY456236 in mice and rats. Neuropharmacology. 43:2002;308.
107. Shigemoto R., Mizuno N. Metabotropic glutamate receptors- immunocytochemical and in situ hybridization analyses. Ottersen O.P., Storm-Mathisen J. Glutamate. Handbook of Chemical Neuroanatomy. 2000;63-98 Elsevier, Amsterdam.
108. Shigemoto R., Kinoshita A., Wada E., Nomura S., Ohishi H., Takada M., Flor P.J., Neki A., Abe T., Nakanishi S., Mizuno N. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J. Neurosci. 17:1997;7503-7522.
109. Sladeczek F., Pin J.-P., Recasens M., Bockaert J., Weiss S. Glutamate stimulates inositol phosphate formation in striatal neurones. Nature. 317:1985;717-719.
110. Snead O.C. III, Banerjee P.K., Burnham M., Hampson D. Modulation of absence seizures by the GABAA receptor: a critical role for metabotropic glutamate receptor 4 (mGluR4). J. Neurosci. 20:2000;6218-6224.
111. Stoop R., Conquet F., Pralong E. Determination of group I metabotropic glutamate receptor subtypes involved in the frequency of epileptiform activity in vitro using mGluR1 and mGluR5 mutant mice. Neuropharmacology. 44:2003;157-162.
112. Sugiyama H., Ito I., Hirono C. A new type of glutamate receptor linked to inositol phospholipid metabolism. Nature. 325:1987;531-533.
113. Suzuki K., Mori N., Kittaka H., Iwata Y., Yamada Y., Osonoe K., Niwa S. Anticonvulsant action of metabotropic glutamate receptor agonists in kindled amygdala of rats. Neurosci. Lett. 204:1996;41-44.
114. Tanabe Y., Masu M., Ishii T., Shigemoto R., Nakanishi S. A family of metabotropic glutamate receptors. Neuron. 8:1992;169-179.
115. Tamaru Y., Nomura S., Mizuno N., Shigemoto R. Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites. Neuroscience. 106:2001;481-503.
116. Tang F.R., Lee W.L. Expression of the group II and III metabotropic glutamate receptors in the hippocampus of patients with mesial temporal lobe epilepsy. J. Neurocytol. 30:2001;137-143.
117. Tang E., Yip P.K., Chapman A.G., Jane D.E., Meldrum B.S. Prolonged anticonvulsant action of glutamate metabotropic receptor agonists in inferior colliculus of genetically epilepsy-prone rats. Eur. J. Pharmacol. 327:1997;109-115.
118. Tang F.R., Lee W.L., Yang J., Sim M.K., Ling E.A. Expression of metabotropic glutamate receptor 8 in the rat hippocampus after pilocarpine induced status epilepticus. Neurosci. Lett. 300:2001;137-140.
119. Tang F.R., Lee W.L., Yang J., Sim M.K., Ling E.A. Expression of metabotropic glutamate receptor 1 in the hippocampus of rat pilocarpine induced status epilepticus. Epilepsy Res. 46:2001;179-189.
120. Tang F.R., Lee W.L., Yeo T.T. Expression of the group I metabotropic glutamate receptor in the hippocampus of patients with mesial temporal lobe epilepsy. J. Neurocytol. 30:2001;403-411.
121. Thomas N.K., Wright R.A., Howson P.A., Kingston A.E., Schoepp D.D., Jane D.E. (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord. Neuropharmacology. 40:2001;311-318.
122. Thomsen C., Klitgaard H., Sheardown M., Jackson H.C., Eskesen K., Jacobsen P., Treppendahl S., Suzdak P.D. (S)-4-carboxy-3-hydroxyphenylglycine, an antagonist of metabotropic glutamate receptor (mGluR)1a and an agonist of mGluR2, protects against audiogenic seizures in DBA/2 mice. J. Neurochem. 62:1994;2492-2495.
123. Thuault S.J., Davies C.H., Randall A.D., Collingridge G. Group I mGluRs modulate the pattern of non-synaptic epileptiform activity in the hippocampus. Neuropharmacology. 43:2002;141-146.
124. Tizzano J.P., Griffey K.I., Johnson J.A., Fix A.S., Helton D.R., Schoepp D.D. Intracerebral 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid ((1S,3R)-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor antagonists. Neurosci. Lett. 162:1993;12-16.
125. Tizzano J.P., Griffey K.I., Schoepp D.D. Induction or protection of limbic seizures in mice by mGluR subtype selective agonists. Neuropharmacology. 34:1995;1063-1067.
126. Ulas J., Satou T., Ivins K.J., Kesslak J.P., Cotman C.W., Balázs R. Expression of metabotropic glutamate receptor 5 is increased in astrocytes after kainate-induced epileptic seizures. Glia. 30:2000;352-361.
127. Varney M.A., Cosford N.D.P., Jachec C., Rao S.P., Sacaan A., Lin F.-F., Bleicher L., Santori E.M., Flor P.J., Allgeier H., Gasparini F., Kuhn R., Hess S.D., Velicelebi G., Johnson E.C. SIB-1757 and SIB-1893: Selective, noncompetitive antagonists of metabotropic glutamate receptor type 5. J. Pharmacol. Exp. Ther. 290:1999;170-181.
128. Winder D.G., Conn J.P. Roles of metabotropic glutamate receptors in glial function and glial-neuronal communication. J. Neurosci. Res. 46:1996;131-137.
129. Yip P.K., Meldrum B.S., Rattray M. Elevated levels of Group-III metabotropic glutamate receptors in the inferior colliculus of genetically epilepsy-prone rats following intracollicular administration of L-serine-O-phosphate. J. Neurochem. 78:2001;18-23.